ArticleAIDS (London, England)2025

Cost-effectiveness of long-acting cabotegravir/rilpivirine for people with HIV and adherence challenges at the Ward 86 clinic: an intermediate outcome analysis.

Elliot Marseille et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.